MED vs. AFRI, PLIN, MAMA, TDUP, LWAY, FREE, ALCO, LMNR, CDZI, and CSV
Should you be buying Medifast stock or one of its competitors? The main competitors of Medifast include Forafric Global (AFRI), China Xiangtai Food (PLIN), Mama's Creations (MAMA), ThredUp (TDUP), Lifeway Foods (LWAY), Whole Earth Brands (FREE), Alico (ALCO), Limoneira (LMNR), Cadiz (CDZI), and Carriage Services (CSV). These companies are all part of the "consumer staples" sector.
Medifast (NYSE:MED) and Forafric Global (NASDAQ:AFRI) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.
Medifast currently has a consensus target price of $53.50, suggesting a potential upside of 114.00%. Given Medifast's higher possible upside, equities research analysts plainly believe Medifast is more favorable than Forafric Global.
Medifast has higher revenue and earnings than Forafric Global.
In the previous week, Medifast had 2 more articles in the media than Forafric Global. MarketBeat recorded 3 mentions for Medifast and 1 mentions for Forafric Global. Medifast's average media sentiment score of 0.19 beat Forafric Global's score of 0.00 indicating that Medifast is being referred to more favorably in the media.
Medifast has a net margin of 7.55% compared to Forafric Global's net margin of 0.00%. Medifast's return on equity of 36.64% beat Forafric Global's return on equity.
Medifast received 383 more outperform votes than Forafric Global when rated by MarketBeat users.
Medifast has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Forafric Global has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500.
95.5% of Medifast shares are held by institutional investors. Comparatively, 5.5% of Forafric Global shares are held by institutional investors. 2.1% of Medifast shares are held by insiders. Comparatively, 13.5% of Forafric Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Medifast beats Forafric Global on 11 of the 13 factors compared between the two stocks.
Get Medifast News Delivered to You Automatically
Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Medifast Competitors List
Related Companies and Tools
